Maravai LifeSciences Holdings, Inc. Operating Lease Right-of-Use Assets
Maravai LifeSciences Holdings, Inc. (MRVI) had Operating Lease Right-of-Use Assets of $39.26 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-02-26
- 2025-12-31: Operating Lease, Right-of-Use Asset $39.26M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $52.55M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $59.75M.
- 2023-09-30: Operating Lease, Right-of-Use Asset $62.86M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $39.26M 10-K · filed 2026-02-26 |
| 2024-12-31 | $52.55M 10-K · filed 2026-02-26 |
| 2023-12-31 | $59.75M 10-K · filed 2025-03-18 |
| 2023-09-30 | $62.86M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $65.01M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $67.14M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $63.90M 10-K · filed 2024-02-29 |
| 2022-09-30 | $54.12M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $47.23M 10-Q · filed 2022-08-05 |
| 2021-12-31 | $49.09M 10-K · filed 2023-02-28 |